U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT06890520) titled 'Neurometabolic Profile of Individuals With Primary Mitochondrial Disease' on Feb. 19.
Brief Summary: Primary Mitochondrial Disease (PMD) is a genetic neurometabolic disorder, leading to central nervous system degeneration and increased risk of early mortality. There is a strong link between the pathophysiology of mitochondrial disease and biomarkers related to the biochemistry of redox imbalance, involving the levels of glutathione. Investigators will use Magnetic Resonance Imaging and Spectroscopy to non-invasively measure glutathione and other chemicals in the brain to identify redox imbalance in patients with PMD.
Study Start D...